MDPH Press Release: Alternatives to Discontinued Asthma Medication
/Published November 13, 2024, DPH issued a press release with information to help patients, families, providers, and pharmacists identify and access the best options for timely and effective asthma medications, particularly in the wake of the discontinuation of two commonly used inhaled treatments—Flovent® HFA and Flovent® Diskus by manufacturer GlaxoSmithKline (GSK). Access the full press release here to view key information on alternatives to discontinued asthma medications.